Looking Into Boston Scientific’s Recent Short Interest
Boston Scientific’s (NYSE:BSX) short percent of float has risen 30.88% since its last report. The company recently reported…
8 Analysts Have This to Say About Boston Scientific
Boston Scientific (NYSE:BSX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects
Psychedelics biotech Clearmind Medicine Inc. (NASDAQ: CMND) has successfully completed two drug discovery projects with leading scientists at the Hebrew University of Jerusalem.
Benzinga’s Top Ratings Upgrades, Downgrades For December 22, 2022
Upgrades According to DA Davidson, the prior rating for Helen Of Troy Ltd (NASDAQ:HELE) was changed from Neutral…
Mizuho Initiates Coverage On Boston Scientific with Neutral Rating, Announces Price Target of $52
Mizuho analyst Anthony Petrone initiates coverage on Boston Scientific (NYSE:BSX) with a Neutral rating and announces Price Target of $52.
Citigroup Reinstates Buy on Boston Scientific, Announces $54 Price Target
Citigroup analyst Joanne Wuensch reinstates Boston Scientific (NYSE:BSX) with a Buy and announces $54 price target.
Truist Securities Maintains Buy on Boston Scientific, Raises Price Target to $54
Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and raises the price target from $50 to $54.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Boston Scientific Announced Strategic Investment to Acquire up to 65% Stake of Acotec Scientific Holdings Limited for Upfront Cash Payment of ~$523M
Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acotec" and 6669.HK) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of int
What 4 Analyst Ratings Have To Say About Boston Scientific
Analysts have provided the following ratings for Boston Scientific (NYSE:BSX) within the last quarter: Bullish Somewhat Bullish Indifferent…